Company Overview - MindBio Therapeutics Corp. is a biotechnology company based in Vancouver, British Columbia, specializing in clinical health research and the development of AI-powered health prediction technologies [6] - The company has created a world-first AI prediction tool for drug and alcohol intoxication detection using voice analytics [6] Recent Developments - MindBio has listed its common shares for trading on the OTCQB Market, expanding its reach to US investors and a larger audience interested in AI and predictive health technologies [5][2] - The company is launching an extended roadshow in the USA to promote its voice and AI-powered drug and alcohol intoxication technology [2] Technology and Innovation - MindBio has developed an AI model that utilizes over 50 million data points to predict alcohol intoxication with high accuracy based solely on human voice [3] - The company successfully launched the Booze AI app in 2025, which estimates actual blood alcohol concentration levels [3] - MindBio is also working on an enterprise version and new platform-level technology for health prediction, aiming to expand its applications in workplace environments, call centers, mental health, and law enforcement [4] Future Prospects - The company plans to make announcements regarding the progress of its new technology, products, markets, and potential commercial applications in the near future [4]
MindBio Lists for Trading on OTCQB Market